fbpx
BAD Investments
BAD Investments
BAD Investments

Meet BAD, your next vice.

What was BAD is now Good

  • Loading stock data...
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
 
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments
BAD Investments

Be Bold, Be Bad

It's Time to Capitalize on Being BAD

Welcome to BAD, the ETF defined by the Betting, Alcohol & Drug industries.

The B.A.D. ETF (BAD) is a large cap fund designed to track the EQM BAD Index (BADIDX), which tracks price movements of a portfolio of U.S. listed companies with exposure to the following B.A.D. market segments: Betting, Alcohol, Cannabis, and Drugs (Pharmaceuticals and Biotechnology).

BAD Investments
Fund Overview & Pricing

Date as of Market Close on 09/26/2022

B.A.D. ETF

Fund Name

BAD

Fund Ticker

53656F235

CUSIP

$7,471,056.02

Net Assets

680,000

Shares Outstanding

$10.99

NAV

$-0.02

NAV Change Dollars

-0.19%

NAV Change Percentage

$11.01

Market Price

$0.01

Market Price Change Dollars

0.08%

Market Price Change Percentage

0.17%

Premium/Discount Percentage

09/26/2022

Rate Date

0.40%

Median 30 Day Spread Percentage

Fund Details

As of 06/30/2022

B.A.D. ETF

Fund Name

12/22/21

Fund Inception

BAD

Ticker

NYSE

Primary Exchange

55

Fund Holdings

BAD.NV

NAV Symbol

Indexed

Management Style

Quarterly

Rebalance Frequency

0.75%

Expense Ratio

53656F235

CUSIP

N/A

30-Day SEC Yield

BAD Performance Chart

Past performance is not indicative of future results. You cannot invest directly in an index. Index performance does not represent actual fund or portfolio performance. A fund or portfolio may differ significantly from the securities included in the index. Index performance assumes reinvestment of dividends but does not reflect any management fees, transaction costs, brokerage commissions on transactions. Such fees, expense and commissions would reduce returns.

BAD Investments

Date as of 07/31/2022

YTD
1M
3M
6M
1Y
Inception
1 Year
Since Inception
2021
Total Return (%)
-16.86
5.76
-5.00
-9.97
x.xx%
-16.53
Market Price (%)
-17.11
6.08
-5.05
-9.91
x.xx%
-16.48
Total Return (%)
x.xx%
x.xx%
Market Price (%)
x.xx%
x.xx%
Total Return (%)
x.xx%
Market Price (%)
x.xx%

The cumulative data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 833.333.9383.

Short-term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns. Market price is the price at which shares in the ETF can be bought or sold on the exchanges during trading hours, while the net asset value (NAV) represents the value of each share’s portion of the fund’s underlying assets and cash at the end of the trading day.

BAD Top Holdings

BAD Investments

Date as of Market Close 09/26/2022

Date
Account
Stock Ticker
C U S I P
Security Name
Shares
Price
Market Value
Weightings
Net Assets
Shares Outstanding
Creation Units
Money Market Flag
09/28/2022
BAD
ABBV
00287Y109
ABBVIE INC
889
$141.72
$125,989.08
1.67%
$7,529,980.00
680000
34
 
09/28/2022
BAD
ABEV
02319V103
AMBEV SA
71,708
$2.83
$202,933.64
2.70%
$7,529,980.00
680000
34
 
09/28/2022
BAD
ALNY
02043Q107
ALNYLAM PHARMACEUTICALS INC
540
$202.61
$109,409.40
1.45%
$7,529,980.00
680000
34
 
09/28/2022
BAD
AMGN
031162100
AMGEN INC
507
$225.99
$114,576.93
1.52%
$7,529,980.00
680000
34
 
09/28/2022
BAD
AZN
046353108
ASTRAZENECA PLC
2,043
$53.24
$108,769.32
1.44%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BALY
05875B106
BALLYS CORPORATION
5,962
$19.86
$118,405.32
1.57%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BF/B
115637209
BROWN FORMAN CORP
2,894
$67.50
$195,345.00
2.59%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BIIB
09062X103
BIOGEN INC
600
$197.79
$118,674.00
1.58%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BMY
110122108
BRISTOL-MYERS SQUIBB CO
1,794
$70.36
$126,225.84
1.68%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BNTX
09075V102
BIONTECH SE
855
$130.30
$111,406.50
1.48%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BUD
03524A108
ANHEUSER BUSCH INBEV SA/NV
4,280
$45.16
$193,284.80
2.57%
$7,529,980.00
680000
34
 
09/28/2022
BAD
BYD
103304101
BOYD GAMING CORP
2,623
$46.95
$123,149.85
1.64%
$7,529,980.00
680000
34
 
09/28/2022
BAD
CCU
204429104
COMPANIA CERVECERIAS UNIDAS S SPONSORED ADR
19,077
$9.60
$183,139.20
2.43%
$7,529,980.00
680000
34
 
09/28/2022
BAD
CGC
138035100
CANOPY GROWTH CORP
60,548
$2.86
$173,167.28
2.30%
$7,529,980.00
680000
34
 
09/28/2022
BAD
CHDN
171484108
CHURCHILL DOWNS INC
719
$182.31
$131,080.89
1.74%
$7,529,980.00
680000
34
 
09/28/2022
BAD
CRON
22717L101
CRONOS GROUP INC
68,662
$2.90
$199,119.80
2.64%
$7,529,980.00
680000
34
 
09/28/2022
BAD
CZR
12769G100
CAESARS ENTERTAINMENT INC NEW COM
3,120
$32.94
$102,772.80
1.36%
$7,529,980.00
680000
34
 
09/28/2022
BAD
DEO
25243Q205
DIAGEO PLC
1,198
$167.07
$200,149.86
2.66%
$7,529,980.00
680000
34
 
09/28/2022
BAD
DKNG
26142V105
DRAFTKINGS INC NEW
8,559
$15.32
$131,123.88
1.74%
$7,529,980.00
680000
34
 
09/28/2022
BAD
EVRI
30034T103
EVERI HLDGS INC
7,865
$16.04
$126,154.60
1.68%
$7,529,980.00
680000
34
 
09/28/2022
BAD
GDEN
381013101
GOLDEN ENTMT INC
3,636
$34.36
$124,932.96
1.66%
$7,529,980.00
680000
34
 
09/28/2022
BAD
GILD
375558103
GILEAD SCIENCES INC
1,914
$62.63
$119,873.82
1.59%
$7,529,980.00
680000
34
 
09/28/2022
BAD
GSK
37733W204
GSK PLC
3,929
$28.66
$112,605.14
1.50%
$7,529,980.00
680000
34
 
09/28/2022
BAD
IGT
G4863A108
INTERNATIONAL GAME TECHNOLOGY SHS USD
8,147
$15.67
$127,663.49
1.70%
$7,529,980.00
680000
34
 
09/28/2022
BAD
JNJ
478160104
JOHNSON & JOHNSON
754
$164.94
$124,364.76
1.65%
$7,529,980.00
680000
34
 
09/28/2022
BAD
LLY
532457108
LILLY ELI & CO
395
$311.10
$122,884.50
1.63%
$7,529,980.00
680000
34
 
09/28/2022
BAD
LNW
80874P109
LIGHT & WONDER INC
3,022
$43.27
$130,761.94
1.74%
$7,529,980.00
680000
34
 
09/28/2022
BAD
LVS
517834107
LAS VEGAS SANDS CORP
3,839
$39.72
$152,485.08
2.03%
$7,529,980.00
680000
34
 
09/28/2022
BAD
MCRI
609027107
MONARCH CASINO & RESORT INC
2,416
$55.78
$134,764.48
1.79%
$7,529,980.00
680000
34
 
09/28/2022
BAD
MGM
552953101
MGM RESORTS INTERNATIONAL
4,237
$29.98
$127,025.26
1.69%
$7,529,980.00
680000
34
 
09/28/2022
BAD
MGPI
55303J106
MGP INGREDIENTS INC NEW
1,828
$100.85
$184,353.80
2.45%
$7,529,980.00
680000
34
 
09/28/2022
BAD
MLCO
585464100
MELCO RESORTS AND ENTMNT LTD ADR
27,304
$6.39
$174,472.56
2.32%
$7,529,980.00
680000
34
 
09/28/2022
BAD
MRK
58933Y105
MERCK & CO INC
1,426
$85.84
$122,407.84
1.63%
$7,529,980.00
680000
34
 
09/28/2022
BAD
MRNA
60770K107
MODERNA INC
884
$122.23
$108,051.32
1.43%
$7,529,980.00
680000
34
 
09/28/2022
BAD
NAPA
26414D106
DUCKHORN PORTFOLIO INC
11,474
$14.31
$164,192.94
2.18%
$7,529,980.00
680000
34
 
09/28/2022
BAD
NVO
670100205
NOVO-NORDISK A S
1,177
$95.90
$112,874.30
1.50%
$7,529,980.00
680000
34
 
09/28/2022
BAD
NVS
66987V109
NOVARTIS AG
1,532
$74.65
$114,363.80
1.52%
$7,529,980.00
680000
34
 
09/28/2022
BAD
PENN
707569109
PENN ENTERTAINMENT INC
4,495
$26.53
$119,252.35
1.58%
$7,529,980.00
680000
34
 
09/28/2022
BAD
PFE
717081103
PFIZER INC
2,653
$44.09
$116,970.77
1.55%
$7,529,980.00
680000
34
 
09/28/2022
BAD
REGN
75886F107
REGENERON PHARMACEUTICALS
175
$695.01
$121,626.75
1.62%
$7,529,980.00
680000
34
 
09/28/2022
BAD
RPRX
G7709Q104
ROYALTY PHARMA PLC
2,895
$40.23
$116,465.85
1.55%
$7,529,980.00
680000
34
 
09/28/2022
BAD
RRR
75700L108
RED ROCK RESORTS INC
3,723
$35.23
$131,161.29
1.74%
$7,529,980.00
680000
34
 
09/28/2022
BAD
RSI
782011100
RUSH STREET INTERACTIVE INC
28,242
$3.95
$111,555.90
1.48%
$7,529,980.00
680000
34
 
09/28/2022
BAD
SAM
100557107
BOSTON BEER INC
615
$324.67
$199,672.05
2.65%
$7,529,980.00
680000
34
 
09/28/2022
BAD
SGEN
81181C104
SEAGEN INC
813
$135.35
$110,039.55
1.46%
$7,529,980.00
680000
34
 
09/28/2022
BAD
SGHC
G8588X103
SUPER GROUP SGHC LIMITED
35,939
$3.86
$138,724.54
1.84%
$7,529,980.00
680000
34
 
09/28/2022
BAD
SNY
80105N105
SANOFI
3,097
$37.22
$115,270.34
1.53%
$7,529,980.00
680000
34
 
09/28/2022
BAD
SRAD
H8088L103
SPORTRADAR GROUP AG
13,322
$8.81
$117,366.82
1.56%
$7,529,980.00
680000
34
 
09/28/2022
BAD
STZ
21036P108
CONSTELLATION BRANDS INC
848
$232.73
$197,355.04
2.62%
$7,529,980.00
680000
34
 
09/28/2022
BAD
TAK
874060205
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS
9,203
$12.80
$117,798.40
1.56%
$7,529,980.00
680000
34
 
09/28/2022
BAD
TAP
60871R209
MOLSON COORS BEVERAGE CO
4,075
$47.59
$193,929.25
2.58%
$7,529,980.00
680000
34
 
09/28/2022
BAD
TLRY
88688T100
TILRAY BRANDS INC
64,548
$2.80
$180,734.40
2.40%
$7,529,980.00
680000
34
 
09/28/2022
BAD
VRTX
92532F100
VERTEX PHARMACEUTICALS INC
430
$284.74
$122,438.20
1.63%
$7,529,980.00
680000
34
 
09/28/2022
BAD
WYNN
983134107
WYNN RESORTS LTD
2,332
$66.56
$155,217.92
2.06%
$7,529,980.00
680000
34
 
09/28/2022
BAD
Cash&Other
Cash&Other
Cash & Other
11,291
$1.00
$11,290.50
0.15%
$7,529,980.00
680000
34
Y

Let’s Roll

Reasons to Invest in BAD

01

Growth Opportunity & Changing Trends

Expansion of Legalization in Betting & Cannabis may provide growth into new markets

New pharmaceutical developments are critical to the economy

Business-to-consumer trends has increased accessibility which may benefit each B.A.D. Industry

02

Potential for Attractive & Controlled Return

Diversification in 3 industries may reduce single industry or sector risk*.

Industries & products are staples of society and human behavior

The B.A.D. Industries have demonstrated willingness to adapt to their consumers and grow through new developments and consumer trends

03

Rooted in History

Historically, B.A.D. industries have endured multiple economic cycles and demonstrated to be profitable businesses

Adapted and embraced political pressures and regulations to improve their business practices

If the past is any indicator for the future trends, consumers will continue to need medicines, consume alcohol, and gamble.

04

Minimal Technology Exposure

Technology & Growth stocks typically trades at higher multiples which has historically been negatively impacted in a rising interest rate environment that the Fed has recently indicated to moderate inflation.

05

COVID-19 Reopening

We believe the B.A.D. industries will benefit in a post-pandemic environment as consumers may seek more forms of entertainment but also rely on vaccines and therapies offered by the pharmaceutical industry.

06

Contra-ESG

We believe that environmental, social, and governance (ESG) funds may be overvalued and oversaturated in a space that has yet to achieve any significant cash flows or profitability. In addition there is a lack of clarity in what constitutes a company to be ESG. *ESG is an approach to evaluating the extent to which a corporation works on behalf of social goals that go beyond the role of a corporation to maximize profits on behalf of the corporation's shareholders.

Let’s Roll

Reasons to Invest in BAD

01 / 06

NYSE: BAD

Forget Add To Cart, Start Investing Today